TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease

Biochemical and Biophysical Research Communications

Volumn 424, Issue 3, 2012, Pages 404-408

  Lee, Ji Hyun ^a,b   Lee, Jong Min ^a   Ramos, Eliana Marisa ^a,c   Gillis, Tammy ^a   Mysore, Jayalakshmi S ^a   Kishikawa, Shotaro ^a   Hadzi, Tiffany ^d   Hendricks, Audrey E ^e   Hayden, Michael R ^f   Morrison, Patrick J ^g,h   Nance, Martha ⁱ   Ross, Christopher A ^j   Margolis, Russell L ^j   Squitieri, Ferdinando ^k   Gellera, Cinzia ^l   Gomez Tortosa, Estrella ^m   Ayuso, Carmen ^m   Suchowersky, Oksana ⁿ   Trent, Ronald J ^o   McCusker, Elizabeth ^p   Novelletto, Andrea ^q   Frontali, Marina ^r   Jones, Randi ^s   Ashizawa, Tetsuo ^t   Frank, Samuel ^d   Saint Hilaire, Marie Helene ^d   Hersch, Steven M ^a   Rosas, Herminia D ^a   Lucente, Diane ^a   Harrison, Madaline B ^u   Zanko, Andrea ^v   Abramson, Ruth K ^w   Marder, Karen ^x   Sequeiros, Jorge ^c,y   Bernhard Landwehrmeyer, G ^z   Shoulson, Ira ^aa   Myers, Richard H ^d   MacDonald, Marcy E ^a   Gusella, James F ^a,ab   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Yonsei University College of Medicine   (South Korea)

^c UNIVERSITY OF PORTO   (Portugal)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^h UNIVERSITY OF ULSTER   (United Kingdom)

ⁱ HENNEPIN COUNTY MEDICAL CENTER   (United States)

^j JOHNS HOPKINS UNIVERSITY   (United States)

^k IRCCS NEUROMED   (Italy)

^l DEPARTMENT OF NEUROSURGERY   (Italy)

^m Hospital UniversitarioFundación Jiménez Díaz   (Spain)

ⁿ UNIVERSITY OF ALBERTA   (Canada)

^o UNIVERSITY OF SYDNEY   (Australia)

^p WESTMEAD HOSPITAL   (Australia)

^q UNIVERSITY OF ROME TOR VERGATA   (Italy)

^r Institute of Neurobiology and Molecular Medicine   (Italy)

^s EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^t UNIVERSITY OF FLORIDA   (United States)

^u UNIVERSITY OF VIRGINIA   (United States)

^v UNIVERSITY OF CALIFORNIA   (United States)

^w UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^x NewYork Presbyterian Hospital   (United States)

^y UNIVERSITY OF PORTO   (Portugal)

^z UNIVERSITY OF ULM   (Germany)

^aa GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^ab HARVARD MEDICAL SCHOOL   (United States)

more..

Author keywords

Age at onset; Genetic modifier; GRIK2; Huntington's disease (HD)

Indexed keywords

GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR IONOTROPIC KAINATE 2; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; AGE DISTRIBUTION; ARTICLE; DNA DETERMINATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; NEUROTRANSMISSION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

3' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALLELES; CHILD; CHILD, PRESCHOOL; CODON, TERMINATOR; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, KAINIC ACID; TRINUCLEOTIDE REPEATS; YOUNG ADULT;

EID: 84864757021     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.06.120     Document Type: Article

References (25)

1. Walker F.O. Huntington's disease. The Lancet 2007, 369:218-228.
2. Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 1993, 72:971-983.
3. Duyao M., Ambrose C., Myers R., Novelletto A., Persichetti F., Frontali M., Folstein S., Ross C., Franz M., Abbott M. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nature Genetics 1993, 4:387-392.
4. Andrew S.E., Goldberg Y.P., Kremer B., Telenius H., Theilmann J., Adam S., Starr E., Squitieri F., Lin B., Kalchman M.A. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nature Genetics 1993, 4:398-403.
5. Snell R.G., MacMillan J.C., Cheadle J.P., Fenton I., Lazarou L.P., Davies P., MacDonald M.E., Gusella J.F., Harper P.S., Shaw D.J. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nature Genetics 1993, 4:393-397.
6. Djousse L., Knowlton B., Hayden M.R., Almqvist E.W., Brinkman R.R., Ross C.A., Margolis R.L., Rosenblatt A., Durr A., Dode C., Morrison P.J., Novelletto A., Frontali M., Trent R.J., McCusker E., Gomez-Tortosa E., Mayo Cabrero D., Jones R., Zanko A., Nance M., Abramson R.K., Suchowersky O., Paulsen J.S., Harrison M.B., Yang Q., Cupples L.A., Mysore J., Gusella J.F., MacDonald M.E., Myers R.H. Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16. Neurogenetics 2004, 5:109-114.
7. Gusella J.F., MacDonald M.E. Huntington's disease: the case for genetic modifiers. Genome Med 2009, 1:80.
8. Wexler N.S., Lorimer J., Porter J., Gomez F., Moskowitz C., Shackell E., Marder K., Penchaszadeh G., Roberts S.A., Gayn J., Brocklebank D., Cherny S., Cardon L.R., Gray J., Dlouhy S.R., Wiktorski S., Hodes M.E., Conneally P.M., Penney J.B., Gusella J., Cha J., Irizarry M., Rosas D., Hersch S., Hollingsworth Z., MacDonald M., Young A.B., Andresen J.M., Housman D.E., De Young M.M., Bonilla E., Stillings T., Negrette A., Snodgrass S.R., Martinez-Jaurrieta M.D., Ramos-Arroyo M.A., Bickham J., Ramos J.S., Marshall F., Shoulson I., Rey G.J., Feigin A., Arnheim N., Acevedo-Cruz A., Acosta L., Alvir J., Fischbeck K., Thompson L.M., Young A., Dure L., O'Brien C.J., Paulsen J., Brickman A., Krch D., Peery S., Hogarth P., Higgins D.S., Landwehrmeyer B. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:3498-3503.
9. Paschen W., Blackstone C.D., Huganir R.L., Ross C.A. Human GluR6 kainate receptor (GRIK2): molecular cloning, expression, polymorphism, and chromosomal assignment. Genomics 1994, 20:435-440.
10. Rubinsztein D.C., Leggo J., Chiano M., Dodge A., Norbury G., Rosser E., Craufurd D. Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:3872-3876.
11. MacDonald M.E., Vonsattel J.P., Shrinidhi J., Couropmitree N.N., Cupples L.A., Bird E.D., Gusella J.F., Myers R.H. Evidence for the GluR6 gene associated with younger onset age of Huntington's disease. Neurology 1999, 53:1330-1332.
12. Naz P., Vuillaume I., Deste A., Pasquier F., Sablonnire B. Mutation analysis and association studies of the ubiquitin carboxy-terminal hydrolase L1 gene in Huntington's disease. Neuroscience Letters 2002, 328:1-4.
13. Chattopadhyay B., Ghosh S., Gangopadhyay P.K., Das S.K., Roy T., Sinha K., Jha D.K., Mukherjee S.C., Chakraborty A., Singhal B.S., Bhattacharya A.K., Bhattacharyya N.P. Modulation of age at onset in Huntington's disease and spinocerebellar ataxia type 2 patients originated from eastern India. Neuroscience Letters 2003, 345:93-96.
14. Cannella M., Gellera C., Maglione V., Giallonardo P., Cislaghi G., Muglia M., Quattrone A., Pierelli F., Di Donato S., Squitieri F. The gender effect in juvenile Huntington disease patients of Italian origin, American journal of medical genetics. Part B, Neuropsychiatric genetics 2004, 125B:92-98.
15. Zeng W., Gillis T., Hakky M., Djousse L., Myers R.H., MacDonald M.E., Gusella J.F. Genetic analysis of the GRIK2 modifier effect in Huntington's disease. BMC Neurosci 2006, 7:62.
16. Warner J.P., Barron L.H., Brock D.J. A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes. Molecular and Cellular Probes 1993, 7:235-239.
17. Lee J.M., Ramos E.M., Lee J.H., Gillis T., Mysore J.S., Hayden M.R., Warby S.C., Morrison P., Nance M., Ross C.A., Margolis R.L., Squitieri F., Orobello S., Di Donato S., Gomez-Tortosa E., Ayuso C., Suchowersky O., Trent R.J., McCusker E., Novelletto A., Frontali M., Jones R., Ashizawa T., Frank S., Saint-Hilaire M.H., Hersch S.M., Rosas H.D., Lucente D., Harrison M.B., Zanko A., Abramson R.K., Marder K., Sequeiros J., Paulsen J.S., Landwehrmeyer G.B., Myers R.H., Macdonald M.E., Gusella J.F. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology 2012.
18. Arning L., Mont D., Hansen W., Wieczorek S., Jagiello P., Akkad D.A., Andrich J., Kraus P.H., Saft C., Epplen J.T. ASK1 and MAP2K6 as modifiers of age at onset in Huntington's disease. Journal of Molecular Medicine 2008, 86:485-490.
19. Dhaenens C., Burnouf S., Simonin C., Van Brussel E., Duhamel A., Defebvre L., Duru C., Vuillaume I., Cazeneuve C., Charles P., Maison P., Debruxelles S., Verny C., Gervais H., Azulay J., Tranchant C., Bachoud-Levi A., Drr A., Bue L., Krystkowiak P., Sablonnire B., Blum D. A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease. Neurobiology of disease 2009, 35:474-476.
20. Metzger S., Bauer P., Tomiuk J., Laccone F., Didonato S., Gellera C., Soliveri P., Lange H.W., Weirich-Schwaiger H., Wenning G.K., Melegh B., Havasi V., Balik L., Wieczorek S., Arning L., Zaremba J., Sulek A., Hoffman-Zacharska D., Basak A.N., Ersoy N., Zidovska J., Kebrdlova V., Pandolfo M., Riba P., Kadasi L., Kvasnicova M., Weber B.H., Kreuz F., Dose M., Stuhrmann M., Riess O. The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease. Neurogenetics 2006, 7:27-30.
21. TaherzadehFard E., Saft C., Andrich J., Wieczorek S., Arning L. PGC-1alpha as modifier of onset age in Huntington disease. Molecular neurodegeneration 2009, 4:10-11.
22. Kishikawa S., Li J., Gillis T., Hakky M., Warby S., Hayden M., MacDonald M.E., Myers R.H., Gusella J.F. Brain-derived neurotrophic factor does not influence age at neurologic onset of Huntington's disease. Neurobiology of disease 2006, 24:280-285.
23. Di Maria E., Marasco A., Tartari M., Ciotti P., Abbruzzese G., Novelli G., Bellone E., Cattaneo E., Mandich P. No evidence of association between BDNF gene variants and age-at-onset of Huntington's disease. Neurobiology of disease 2006, 24:274-279.
24. Metzger S., Bauer P., Tomiuk J., Laccone F., Didonato S., Gellera C., Mariotti C., Lange H.W., Weirich-Schwaiger H., Wenning G.K., Seppi K., Melegh B., Havasi V., Balik L., Wieczorek S., Zaremba J., Hoffman-Zacharska D., Sulek A., Basak A.N., Soydan E., Zidovska J., Kebrdlova V., Pandolfo M., Riba P., Kadasi L., Kvasnicova M., Weber B.H., Kreuz F., Dose M., Stuhrmann M., Riess O. Genetic analysis of candidate genes modifying the age-at-onset in Huntington's disease. Human Genetics 2006, 120:285-292.
25. Andresen J.M., Gayn J., Cherny S.S., Brocklebank D., Alkorta-Aranburu G., Addis E.A., Cardon L.R., Housman D.E., Wexler N.S. Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds. Journal of Medical Genetics 2007, 44:44-50.